RECORD // Company
Chemomab Therapeutics Ltd.
Formerly: Anchiano Therapeutics Ltd.; BioCancell Ltd.
Built 2026-11-22T05:18:40Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- Chemomab Therapeutics Ltd. · the SEC registrant record of this company
2 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2023-03-31, filed 2023-05-11 · accession 0001178913-23-001807
Old data: this filer's newest 10-Q or 10-K in SEC company facts is for the period ended 2023-03-31. No later report has XBRL values.
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $-8,753,000 | 3 months ended 2023-03-31 | 10-Q | 2023-05-11 | 0001178913-23-001807 | 2026-11-22 05:18 UTC | Report an error |
| Cash and cash equivalents | $20,765,000 | at 2023-03-31 | 10-Q | 2023-05-11 | 0001178913-23-001807 | 2026-11-22 05:18 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Revenue, Interest expense.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001534248
- Ticker
- CMMB
- EIN
- 813676773
- CUSIP
- 16385C203
- Record ID
- sx:sec:0001534248
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
28 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-19 | SEC EDGAR company profile | 2026-11-22 05:18 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-19 | SEC EDGAR company profile | 2026-11-22 05:18 UTC | Report an error |
| State of incorporation | L3 | 2026-11-19 | SEC EDGAR company profile | 2026-11-22 05:18 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-19 | SEC EDGAR company profile | 2026-11-22 05:18 UTC | Report an error |
| Business address | KIRYAT ATIDIM, BUILDING 7, TEL AVIV | 2026-11-19 | SEC EDGAR company profile | 2026-11-22 05:18 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-19 | SEC EDGAR company profile | 2026-11-22 05:18 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-8,995,000 | 2025-12-31 | 20-F, XBRL NetIncomeLoss | 2026-11-22 05:18 UTC | Report an error |
| Total assets (at 2025-12-31) | $13,812,000 | 2025-12-31 | 20-F, XBRL Assets | 2026-11-22 05:18 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $12,334,000 | 2025-12-31 | 20-F, XBRL StockholdersEquity | 2026-11-22 05:18 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $7,564,000 | 2025-12-31 | 20-F, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 05:18 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-11,130,000 | 2025-12-31 | 20-F, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 05:18 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $3,000 | 2025-12-31 | 20-F, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-22 05:18 UTC | Report an error |
| Operating lease liabilities (at 2024-12-31) | $324,000 | 2024-12-31 | 20-F, XBRL OperatingLeaseLiability | 2026-11-22 05:18 UTC | Report an error |
| Form D total offering amount (D filed 2024-08-09) | $10,000,000 | 2024-08-09 | D | 2026-11-22 05:18 UTC | Report an error |
| Form D total amount sold (D filed 2024-08-09) | $10,000,000 | 2024-08-09 | D | 2026-11-22 05:18 UTC | Report an error |
| Form D industry group | Biotechnology | 2024-08-09 | D | 2026-11-22 05:18 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2024-08-09 | D | 2026-11-22 05:18 UTC | Report an error |
| Form D date of first sale | 2024-07-29 | 2024-08-09 | D | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #1 (13F as filed): CITADEL ADVISORS LLC | $154,404 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #2 (13F as filed): ADAR1 Capital Management, LLC | $129,600 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #3 (13F as filed): KESTRA PRIVATE WEALTH SERVICES, LLC | $99,970 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #4 (13F as filed): Ikarian Capital, LLC | $83,904 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #5 (13F as filed): RHUMBLINE ADVISERS | $49,457 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #6 (13F as filed): XTX Topco Ltd | $25,899 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #7 (13F as filed): Philadelphia Investment Partners, LLC | $24,300 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #8 (13F as filed): Lido Advisors, LLC | $23,232 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #9 (13F as filed): GAMMA Investing LLC | $7,679 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
| Largest institutional holder #10 (13F as filed): SBI Securities Co., Ltd. | $55 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:18 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-19 Filing 6-K filed
- 2026-11-10 Filing DEFA14A filed
- 2026-11-03 Filing 6-K filed
- 2026-10-30 Filing EFFECT filed
- 2026-10-30 Filing DEFM14A filed
- 2026-10-29 Filing S-4/A filed
- 2026-10-19 Filing 6-K filed
- 2026-10-19 Filing S-4/A filed
- 2026-09-30 Filing 6-K filed
- 2026-09-25 Filing S-4 filed
- 2026-08-19 Filing 6-K filed
- 2026-08-12 Filing DRS filed
- 2026-07-08 Filing 6-K filed
- 2026-06-02 Filing 6-K filed
- 2026-05-14 Filing 6-K filed
- 2026-05-06 Filing 6-K filed
- 2026-04-28 Filing 6-K filed
- 2026-03-23 Filing 20-F filed
- 2026-03-20 Filing 6-K filed
- 2026-03-19 Filing 6-K filed
- 2025-11-21 Filing 6-K filed
- 2025-08-22 Filing 6-K filed
- 2025-08-14 Filing 6-K filed
- 2025-07-25 Filing 6-K filed
- 2025-07-25 Filing 424B5 filed
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No H-1B LCA filed under EIN 813676773 in FY2026 Q3
- H-1B LCAs only (H-1B1 and E-3 excluded); one fiscal quarter (FY2026 Q3) only, earlier quarters not loaded
- No Form 5500 plan filed under sponsor EIN 813676773 for plan year 2025
- Plan year 2025 only (EFAST2 'Latest' file); earlier years not loaded
- No Form 990 found for EIN 813676773
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T05:18:40Z
- DOL OFLC LCA Disclosure Data: checked, nothing found · 2026-11-22T05:18:41Z
- DOL EBSA Form 5500 public datasets: checked, nothing found · 2026-11-22T05:18:41Z
- Propublica 990: checked, nothing found · 2026-11-22T05:18:41Z
- SEC 13F holdings: checked · 2026-11-22T05:18:41Z
- USAspending: checked, nothing found · 2026-11-22T05:18:42Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.